Joseph Saddik | Pharmacology, Toxicology and Pharmaceutical Science | Best Innovation Award

Published on by Academic Excellence

Best Innovation Award

Joseph Saddik
Pfizer,United States

Joseph Saddik
Affiliation Pfizer
Country United States
Scopus ID 57223125865
Documents 2
Citations 25
h-index 2
Subject Area Pharmacology, Toxicology and Pharmaceutical Science
Event International Academic Excellence Awards
ORCID 0000-0003-1490-9517

Joseph Saddik is identified with research in pharmaceutical science, particularly powder rheology, tablet compaction, compactability, and manufacturing-related performance of acetaminophen tablets. His listed publications address formulation and processing variables associated with tablet manufacture and the prediction or mitigation of sticking during compression. [1][2]

Abstract

The research record associated with Joseph Saddik centers on pharmaceutical powder processing and tablet manufacturing. The documented work examines powder rheology, tablet compactability, and sticking behavior, with particular attention to formulation factors, glidant selection, punch-metal effects, and multivariate analytical approaches. These topics are relevant to pharmaceutical manufacturing because powder flow and compaction characteristics can influence tablet quality and process performance. [2][3]

Keywords

Pharmaceutical science; powder rheology; tablet compression; acetaminophen; compactability; sticking; glidants; punch metals; multivariate analysis.

Introduction

Tablet manufacture involves interconnected material and process variables. Acetaminophen is frequently used as a model active pharmaceutical ingredient for studying compression behavior because formulation and processing conditions can affect compaction and manufacturing outcomes. Research examining these relationships can support improved understanding of tablet formation and compression-related defects. [2]

Research Profile

The supplied researcher record lists Pfizer as the institutional affiliation and identifies Pharmacology, Toxicology and Pharmaceutical Science as the subject area. The supplied bibliographic information records two documents, 25 citations, and an h-index of 2, alongside Scopus author identifier 57223125865. These metrics are bibliographic indicators and should be interpreted in relation to database coverage and publication history. [1]

Research Contributions

The documented studies contribute to the characterization of pharmaceutical powders and compressed tablets. One study evaluates powder rheology as a potential predictor of tablet sticking, while another investigates manufacturing and formulation factors affecting acetaminophen compactability. The 2026 study further develops this research direction by examining glidant type and punch-metal selection in high-drug-load acetaminophen tablets. [2][3][4]

Publications

  • Predicting and Mitigating Sticking in High-Drug-Load Acetaminophen Tablets Using a Powder Rheology-Compression Approach: Evaluation of Glidant Type and Punch Metal Selection. Powders, 2026. [4]
  • Investigating the Impact of Manufacturing and Formulation Factors on the Compactability of Acetaminophen Tablets Using Heckel and Multivariate Analysis. International Journal of Pharmaceutical Sciences and Research, 2021. [2]
  • Evaluation of powder rheology as a potential tool to predict tablet sticking. Powder Technology, 2021. [3]

Research Impact

The reported citation count indicates that the research has received citations within the indexed scholarly literature. Its thematic focus also connects fundamental powder characterization with practical tablet-manufacturing concerns, including sticking and compactability. Such work may be relevant to formulation development and process understanding, although citation metrics alone do not establish practical or clinical impact. [1]

Award Suitability

For consideration in the International Academic Excellence Awards, the documented publication record provides identifiable evidence of research activity in pharmaceutical manufacturing and powder science. The studies present a coherent research theme spanning rheological characterization, compaction analysis, and mitigation of tablet sticking. Award decisions, however, remain subject to the criteria, documentation, and assessment procedures established by the awarding organization. [5]

Conclusion

Joseph Saddik’s documented research is focused on technically specific problems in pharmaceutical tablet manufacture, particularly powder rheology, compactability, and sticking. The available publications demonstrate continuity across these subjects and provide a scholarly basis for describing his research profile within pharmaceutical science. [2][3][4]

References

  1. Elsevier. (n.d.). Scopus author details: Joseph Saddik, Author ID 57223125865. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57223125865
  2. International Journal of Pharmaceutical Sciences and Research. (2021). Investigating the Impact of Manufacturing and Formulation Factors on the Compactability of Acetaminophen Tablets Using Heckel and Multivariate Analysis. DOI: 10.13040/ijpsr.0975-8232.12(2).1240-50
  3. Powder Technology. (2021). Evaluation of powder rheology as a potential tool to predict tablet sticking. DOI: 10.1016/j.powtec.2021.03.062
  4. MDPI. (2026). Predicting and Mitigating Sticking in High-Drug-Load Acetaminophen Tablets Using a Powder Rheology-Compression Approach: Evaluation of Glidant Type and Punch Metal Selection. Powders, 5(3), 31.
    https://doi.org/10.3390/powders5030031
  5. International Academic Excellence Awards. (n.d.). Award program information.
    https://academicexcellenceawards.com/
  6. ORCID. (n.d.). Joseph Saddik, ORCID record 0000-0003-1490-9517.
    https://orcid.org/0000-0003-1490-9517

Dalia Saleh | Neurotoxicology | Best Researcher Award

Published on by Academic Excellence

Prof. Dr. Dalia Saleh | Neurotoxicology | Best Researcher Award

Prof. Dr. Dalia Saleh, National Research Centre, Egypt

Dr. Dalia Osama Abd El Fattah Saleh is a distinguished Egyptian pharmacologist renowned for her extensive research in neurotoxicology, diabetes, and cardiovascular diseases. She earned her Ph.D. in Pharmacology from Cairo University in 2012, focusing on estrogen's effects on vascular changes in insulin-resistant rats. Currently, she serves as an Assistant Professor at the National Research Centre in Cairo, contributing significantly to the field of pharmacology. Dr. Saleh has published numerous articles in reputable journals, highlighting her expertise in molecular pharmacology and toxicology. Her work has garnered over 1,700 citations, reflecting her impact on the scientific community. Beyond research, she has played pivotal roles in quality assurance, aiding her department in achieving ISO certifications. Dr. Saleh's dedication to advancing medical science and mentoring the next generation of researchers underscores her commitment to excellence in pharmacological research.

Professional Profile

Scopus

Orcid

Google Scholar

Suitability Summary for Best Researcher Awards

Based on the provided profile, Dr. Dalia Osama Abd El Fattah Saleh demonstrates substantial qualifications that make her highly suitable for the Research for Best Researcher Award. Her extensive academic background, with a Ph.D. in Pharmacology from Cairo University and over two decades of progressive research experience at the National Research Centre, positions her as a prominent candidate in the field of pharmacological research.

Dr. Saleh’s scholarly journey reflects a strong focus on translational and experimental pharmacology, with particular emphasis on diabetes, cardiovascular diseases, hepatic disorders, and neuropharmacology. Her role progression from Research Assistant to Assistant Professor and Researcher underlines a sustained commitment to scientific advancement. Notably, her leadership in quality assurance and ISO accreditation projects at the NRC demonstrates her organizational impact and dedication to research excellence.

Education 

Dr. Dalia Saleh's academic journey is marked by a steadfast commitment to pharmacological sciences. She obtained her Bachelor of Science in Pharmacy from Cairo University in 2002, graduating with honors. Pursuing advanced studies, she earned her Master of Science in Pharmacology in 2009, with a thesis investigating the effects of rosiglitazone on vascular and biochemical changes in diabetic rats. Her academic pursuits culminated in a Ph.D. in Pharmacology in 2012, where her research delved into estrogen's potential impact on vascular changes associated with insulin resistance in ovariectomized rats. Throughout her educational tenure, Dr. Saleh demonstrated a profound interest in understanding the intricate mechanisms of drug actions and their physiological implications. Her rigorous academic training laid a robust foundation for her subsequent research endeavors, enabling her to contribute significantly to the fields of neuropharmacology and toxicology. Dr. Saleh's educational background reflects her dedication to advancing medical knowledge and improving therapeutic strategies.

Professional Experience 

Dr. Dalia Saleh's professional career spans over two decades, characterized by her contributions to pharmacological research and education. Since 2003, she has been affiliated with the National Research Centre in Cairo, ascending from Research Assistant to Assistant Professor. Her roles have encompassed conducting pivotal research in pharmacology, with a focus on neurotoxicology and metabolic disorders. Dr. Saleh has also been instrumental in quality assurance, leading her department to achieve ISO 9001/2008 and ISO/IEC 17025/2005 certifications, reflecting her commitment to excellence and standardization in research practices. In academia, she has served as a part-time instructor at MSA University and the University of Sadat City, imparting knowledge in pharmacology and supervising student research projects. Her professional journey is marked by a blend of research acumen and dedication to education, positioning her as a respected figure in the pharmacological community. Dr. Saleh's multifaceted experience underscores her role in advancing pharmacological sciences and mentoring future researchers.

Awards and Recognition 

Dr. Dalia Saleh's exemplary work in pharmacology has earned her recognition within the scientific community. Her research contributions, particularly in neurotoxicology and metabolic disorders, have been widely cited, reflecting the impact of her work. She has actively participated in numerous national and international conferences, sharing her findings and collaborating with fellow researchers. Dr. Saleh's commitment to quality in research is evident through her leadership in achieving ISO certifications for her department, a testament to her dedication to excellence. Additionally, her involvement in various workshops and seminars underscores her role in continuous professional development and knowledge dissemination. While specific awards are not detailed, her professional trajectory and contributions signify a career marked by recognition and respect in the field of pharmacology. Dr. Saleh's achievements highlight her as a leading figure in advancing pharmacological research and education.

Research Skills On Neurotoxicology

Dr. Dalia Saleh possesses a comprehensive skill set in pharmacological research, with a particular emphasis on neurotoxicology, diabetes, and cardiovascular diseases. Her expertise encompasses in-vitro pharmacological techniques, molecular pharmacology, and toxicological assessments. She is proficient in conducting complex experiments involving animal models, such as ovariectomy procedures in rats, to study hormonal impacts on vascular functions. Dr. Saleh's research also delves into the biochemical pathways affected by various pharmacological agents, enabling a deeper understanding of drug mechanisms. Her ability to integrate molecular biology with pharmacology allows for a holistic approach to studying disease processes and potential treatments. Furthermore, her involvement in quality assurance and standardization of laboratory practices demonstrates her commitment to research integrity and reproducibility. Dr. Saleh's research skills are further evidenced by her extensive publication record, contributing valuable insights to the scientific community and advancing the field of pharmacology.

  Publication Top Notes

  • Title: HPLC-DAD-MS/MS profiling of phenolics from Securigera securidaca flowers and its anti-hyperglycemic and anti-hyperlipidemic activities
    Authors: RM Ibrahim, AM El-Halawany, DO Saleh, EMBE Naggar, ...
    Citation: Revista Brasileira de Farmacognosia, 25, 134–141
    Year: 2015
    Citations: 181

  • Title: Effects of sulforaphane on D-galactose-induced liver aging in rats: Role of keap-1/nrf-2 pathway
    Authors: DO Saleh, DF Mansour, IM Hashad, RM Bakeer
    Citation: European Journal of Pharmacology, 855, 40–49
    Year: 2019
    Citations: 63

  • Title: Antiviral Activity of Zinc Oxide Nanoparticles Mediated by Plumbago indica L. Extract Against Herpes Simplex Virus Type 1 (HSV-1)
    Authors: MM Melk, SS El-Hawary, FR Melek, DO Saleh, OM Ali, MA El Raey, ...
    Citation: International Journal of Nanomedicine, 8221–8233
    Year: 2021
    Citations: 58

  • Title: Synthesis, vasorelaxant activity, and molecular modeling study of some new phthalazine derivatives
    Authors: FM Awadallah, WI El-Eraky, DO Saleh
    Citation: European Journal of Medicinal Chemistry, 52, 14–21
    Year: 2012
    Citations: 54

  • Title: Genistein ameliorates cyclophosphamide-induced hepatotoxicity by modulation of oxidative stress and inflammatory mediators
    Authors: DF Mansour, DO Saleh, RE Mostafa
    Citation: Open Access Macedonian Journal of Medical Sciences, 5(7), 836
    Year: 2017
    Citations: 52

  • Title: Zeaxanthin Isolated from Dunaliella salina Microalgae Ameliorates Age Associated Cardiac Dysfunction in Rats through Stimulation of Retinoid Receptors
    Authors: FK El-Baz, RA Hussein, DO Saleh, GAR Abdel Jaleel
    Citation: Marine Drugs, 17(5), 290
    Year: 2019
    Citations: 51

  • Title: Cardiorenal protective effect of taurine against cyclophosphamide-induced toxicity in albino rats
    Authors: KA Alhumaidha, DO Saleh, MA Abd El Fattah, WI El-Eraky, H Moawad
    Citation: Canadian Journal of Physiology and Pharmacology, 94(2), 131–139
    Year: 2016
    Citations: 51

  • Title: Ovario-protective effects of genistein against cyclophosphamide toxicity in rats: Role of anti-müllerian hormone and oestradiol
    Authors: DO Saleh, DF Mansour
    Citation: European Journal of Pharmacology, 789, 163–171
    Year: 2016
    Citations: 45

  • Title: Heamatococcus pluvialis ameliorates bone loss in experimentally-induced osteoporosis in rats via the regulation of OPG/RANKL pathway
    Authors: FK El-Baz, DO Saleh, GAA Jaleel, RA Hussein, A Hassan
    Citation: Biomedicine & Pharmacotherapy, 116, 109017
    Year: 2019
    Citations: 44

  • Title: Cisplatin-Induced nephrotoxicity in rats: modulatory role of simvastatin and rosuvastatin against apoptosis and inflammation
    Authors: RE Mostafa, DO Saleh, DF Mansour
    Citation: Journal of Applied Pharmaceutical Science, 8(4), 043–050
    Year: 2018
    Citations: 42

Sijoon Lee | Pathology | Best Researcher Award

Published on by Academic Excellence

Dr. Sijoon Lee | Pathology | Best Researcher Award

Dr. Sijoon Lee, Daegu-Gyeongbuk Medical Innovation Foundation, South Korea

Sijoon Lee is a veterinary biomedical scientist with a Ph.D. from Gyeongsang National University, specializing in microplastic toxicity and exosome-based therapeutics. With over a decade of research and toxicological pathology experience, he has pioneered studies on the effects of microplastics and extracellular vesicles in various biomedical fields. Currently a researcher at the Daegu-Gyeongbuk Medical Innovation Foundation in South Korea, Dr. Lee has contributed significantly to advancing knowledge in toxicology and the development of therapeutic approaches for diseases such as osteoporosis and idiopathic pulmonary fibrosis. His innovative work has earned him recognition in high-impact journals.

Professional Profile

Scopus

Suitability for the Research for Best Researcher Award

Sijoon Lee is highly suitable for the Research for Best Researcher Award based on his extensive contributions to biomedical research, particularly in the areas of microplastic toxicity, exosome-based therapeutics, and osteoporosis treatments. With over 10 years of research experience, Dr. Lee has demonstrated a deep understanding of toxicological pathology and biomedical science. His projects—ranging from the evaluation of drug safety and efficacy to the development of technology for harmful substance evaluation—highlight his innovative approach to addressing critical health issues.

Dr. Lee’s work has made a significant impact, reflected in the publication of over 30 high-impact journal articles and the citation of his research more than 50 times. Notably, his groundbreaking work in microplastic toxicity and the development of therapeutic interventions using exosome-derived technologies has the potential to revolutionize biomedical treatment options. His contributions to drug safety evaluation, especially in collaboration with pharmaceutical companies, also underscore his excellence in translational research, making his work both impactful and relevant.

Education 🎓

Dr. Sijoon Lee obtained his Ph.D. in Veterinary Biomedical Science from Gyeongsang National University. His academic journey has been focused on the intersection of pathology, toxicology, and biomedical innovations, particularly in the study of microplastics and exosome-based therapies. His rigorous training laid the foundation for his research on the safety and efficacy of drug treatments, including those related to osteoporosis. His continuous pursuit of knowledge in toxicological pathology has earned him multiple memberships in prestigious scientific societies and recognition as an expert in his field.

Professional Experience 💼

Dr. Sijoon Lee has over ten years of experience in toxicological pathology and biomedical research. He is currently a researcher at the Daegu-Gyeongbuk Medical Innovation Foundation in South Korea, where he leads research projects on microplastic toxicity, drug efficacy for osteoporosis, and the development of therapeutic medical devices. Dr. Lee has supported several pharmaceutical and biotech companies in their R&D efforts, particularly in conducting toxicity studies and efficacy evaluations. His contributions to the pharmaceutical sector include providing pathological evaluations for FDA/MFDS compliance in preclinical studies and supporting osteoporosis drug development.

Awards and Recognition 🏅

Dr. Sijoon Lee’s research excellence has been acknowledged with numerous accolades, including over 50 citations for his works published in high-impact journals such as International Journal of Molecular Sciences and Polymers. He has received recognition for his contributions to the fields of microplastic toxicity, exosome-based therapeutics, and biomedical research. In addition, Dr. Lee holds multiple granted patents, such as “Composition for the prevention or treatment of liver disease containing fat extract of Gwamegi” and “Stress diagnostic technology using exosome-derived miRNAs.” He is a highly regarded member of multiple toxicology and veterinary societies.

Research Skills On Pathology 🌍

Dr. Sijoon Lee’s research expertise lies in the areas of microplastic toxicity, exosome-based therapeutics, and osteopathic treatments using stem cell-derived extracellular vesicles. His work focuses on understanding the toxicity and biodistribution of microplastics, developing biomarkers for diseases, and advancing the pharmacokinetics of medical materials. Additionally, Dr. Lee has contributed to neurobiology research and nerve regeneration mechanisms. His research aims to improve therapeutic outcomes for diseases like osteoporosis and idiopathic pulmonary fibrosis through cutting-edge biomedical technologies.

Publication Top Notes 📖

  • Title: Osteological analysis of Nyctereutes procyonoides bones excavated from the Gasan-ri archaeological site
    Authors: Lee, S., Choi, J., Won, C.
    Journal: Korean Journal of Veterinary Research
    Year: 2024
    Volume: 64
    Issue: 4
    Article ID: e34
  • Title: Spontaneous type II cell-derived bronchioloalveolar adenoma in a young ICR mouse
    Authors: Sung, M., Sung, S.-E., Choi, J.-H., Kim, D., Lee, S.
    Journal: Laboratory Animals
    Year: 2024
    Volume: 58
    Issue: 6
    Pages: 621–625
  • Title: Proteomic profiling of extracellular vesicles derived from human serum for the discovery of biomarkers in Avascular necrosis
    Authors: Sung, S.-E., Lim, J.-H., Kang, K.-K., Seo, M.-S., Lee, G.W.
    Journal: Clinical Proteomics
    Year: 2024
    Volume: 21
    Issue: 1
    Article ID: 39
  • Title: Extracellular Vesicles from Human Adipose Tissue-Derived Mesenchymal Stem Cells Suppress RANKL-Induced Osteoclast Differentiation via miR122-5p
    Authors: Choi, J.-H., Sung, S.-E., Kang, K.-K., Seo, M.-S., Lee, G.W.
    Journal: Biochemical Genetics
    Year: 2024
    Volume: 62
    Issue: 4
    Pages: 2830–2852
  • Title: Investigation of prunetrin induced G2/M cell cycle arrest and apoptosis via Akt/mTOR/MAPK pathways in hepatocellular carcinoma cells
    Authors: Abusaliya, A., Bhosale, P.B., Kim, H.H., Lee, S., Kim, G.S.
    Journal: Biomedicine and Pharmacotherapy
    Year: 2024
    Volume: 174
    Article ID: 116483
  • Title: Enhanced Dural Repair Using Biodegradable Sealants Based on Photocurable Hyaluronic Acid
    Authors: Lee, H., Lee, S., Seong, K.-Y., Nam, K.H., Yang, S.Y.
    Journal: Macromolecular Bioscience
    Year: 2024
    Volume: 24
    Issue: 4
    Article ID: 2300359
  • Title: Transcriptome analysis revealed the genes and major pathways involved in prunetrin treated hepatocellular carcinoma cells
    Authors: Abusaliya, A., Kim, H.H., Vetrivel, P., Lee, S.J., Kim, G.S.
    Journal: Frontiers in Pharmacology
    Year: 2024
    Volume: 15
    Article ID: 1400186
  • Title: Antioxidant and Antimelanogenic Activities of Lactobacillus kunkeei NCHBL-003 Isolated from Honeybees
    Authors: Lee, Y.-J., Choi, J.-H., Kang, K.-K., Seo, M.-S., Park, J.-H.
    Journal: Microorganisms
    Year: 2024
    Volume: 12
    Issue: 1
    Article ID: 188
  • Title: Discovery and Feasibility Study of Medical Fluorophore 33 as a Novel Theranostic Agent
    Authors: Son, K.H., Lee, D.S., Park, G., Kim, D.-S., Jeon, Y.H.
    Journal: ACS Applied Materials and Interfaces
    Year: 2023
    Volume: 15
    Issue: 39
    Pages: 45539–45548
  • Title: Toxicity and Biodistribution of Fragmented Polypropylene Microplastics in ICR Mice
    Authors: Lee, S., Kim, D., Kang, K.-K., Kim, H.-K., Kim, K.
    Journal: International Journal of Molecular Sciences
    Year: 2023
    Volume: 24
    Issue: 10
    Article ID: 846